试剂
Albumin Blue 580 potassium salt solution (Merck MilliporeSigma 05497)
- 组成
- Albumin Blue 580 potassium salt in supplied solvent
- 配方
- ready-to-use dye solution, catalog 05497
已发布方案版本
- 小鼠/大鼠尿白蛋白定量(Albumin Blue 580 染料结合微量板法) · Prepare working reagent. · 工作试剂组分 2 ml 与 100 ml 缓冲液混合 · 商品化试剂盒组分,catalog 05497
来源版本:protocols.io · vv1 · Peter Havel · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
db/db (Lepr^db) · 已验证适用 · 2型糖尿病 (T2D)(db/db 模型用于肥胖相关胰岛素抵抗和2型糖尿病研究,适用性受遗传背景影响。;已验证适用) · 糖尿病肾病 (DN)(C57BLKS 背景 db/db 模型用于糖尿病肾病研究,仅部分重现人类疾病特征。;已验证适用) · 代谢疾病(db/db 模型用于肥胖及代谢异常研究,适用性受遗传背景影响。;已验证适用) · 糖尿病模型(db/db 模型用于糖尿病机制及干预研究;适用性依据为文献报道。;已验证适用)streptozotocin-induced diabetes C57BL/6 mouse · 已验证适用 · 糖尿病模型(High-dose streptozotocin-induced insulin-deficient diabetic mice were used to study diabetic wound healing and the PNS mechanism; this is not a type 2 diabetes model.;已验证适用) · 糖尿病肾病 (DN)(STZ 糖尿病 C57BL/6 小鼠:HMGB1/系膜与小管间质终点;已验证适用)uninephrectomized db/db mouse (C57BLKS background) · 已验证适用 · 糖尿病肾病 (DN)(UNX 后 db/db 小鼠:加速的蛋白尿、肾小管萎缩与间质纤维化;已验证适用)db/db mouse (C57BL/6 background) · 已验证适用 · 糖尿病肾病 (DN)(C57BL/6 背景 db/db 小鼠:白蛋白尿与系膜基质扩张(较 BKS 缓和的 2 型 DN 背景);已验证适用) · 代谢相关脂肪性肝炎 (MASH)(db/db 瘦素受体缺陷 C57BL/6 背景小鼠:高脂/复合打击下评估肝脏脂肪变、炎症与纤维化进展的遗传肥胖胰岛素抵抗模型;已验证适用)db/db C57BLKS mouse · 已验证适用 · 糖尿病模型(Male C57BL/KsJ-db/db mice examined at 8, 16 and 24 weeks of age with db/+ littermate controls.;已验证适用) · 2型糖尿病 (T2D)(Which renal and metabolic abnormalities develop in db/db mice; db/db mouse kidney and urine at 12 weeks;已验证适用) · 糖尿病肾病 (DN)(C57BLKS 背景 db/db 小鼠:尿白蛋白/ACR、肾小球系膜基质扩张与 GBM 增厚的 2 型糖尿病肾病模型;已验证适用)db/db mouse · 已验证适用 · 糖尿病模型(db/db mice were compared with db/+ controls and with the STZ-HFD model.;已验证适用) · 代谢疾病(db/db 小鼠(背景未报到实体粒度):Lepr db/db 瘦素受体功能缺陷,用于遗传性肥胖与 2 型糖尿病研究。;已验证适用) · 2型糖尿病 (T2D)(Which metabolic and renal abnormalities develop in db/db mice; kidney tissue, urine and serum from db/db mice;已验证适用) · 糖尿病肾病 (DN)(db/db 小鼠(背景按各研究记载):白蛋白尿与肾小管线粒体损伤读出;已验证适用)high-fat diet plus streptozotocin-induced type 2 diabetes C57BL/6J mouse · 已验证适用 · 糖尿病模型(Three groups: non-diabetic, diabetic, and diabetic treated with imeglimin;已验证适用) · 2型糖尿病 (T2D)(Does aerobic exercise alleviate diabetic arterial remodeling through Sirt1?; Male C57BL/6J mice, 6 weeks old; CON, CON-Exe, T2DM and T2DM-Exe groups;已验证适用) · 糖尿病肾病 (DN)(HFD+小剂量 STZ C57BL/6J 小鼠:ACR 升高、足细胞与纤维化终点;已验证适用)ob/ob BTBR mouse · 已验证适用 · 糖尿病模型(BTBR ob/ob mice are described as a robust progressive DN model with severe type 2 diabetes and renal damage.;已验证适用) · 2型糖尿病 (T2D)(Which rodent models and phenotyping methods are appropriate for experimental diabetic nephropathy?; diabetic nephropathy models;已验证适用) · 糖尿病肾病 (DN)(BTBR ob/ob 小鼠:渐进白蛋白尿、GBM 增厚与系膜基质扩张的 2 型 DN 模型;已验证适用)streptozotocin-induced diabetes mouse · 已验证适用 · 糖尿病模型(Review concludes that most available models represent NPDR rather than PDR.;已验证适用) · 糖尿病肾病 (DN)(STZ 诱导糖尿病小鼠(品系按研究记载):白蛋白尿、GBM 增厚与系膜基质扩增;已验证适用)